Patents by Inventor Jacek Nowakowski

Jacek Nowakowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7572914
    Abstract: The invention relates to compounds of the following formula that may be used to inhibits kinases, as well as compositions of matter and kits comprising these compounds. The present invention also relates to methods for inhibiting kinases, as well as treatment methods using compounds according to the present invention.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: August 11, 2009
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Anthony R. Gangloff, Jacek Nowakowski, Bheema R. Paraselli, Jeffrey A. Stafford, Michael G. Tennant
  • Patent number: 7444273
    Abstract: Provided are crystals relating to Aurora/LPL1P-related kinase and its various uses.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: October 28, 2008
    Assignee: Takeda San Diego, Inc.
    Inventors: Ciaran N. Cronin, Mark W. Knuth, Duncan E. McRee, Jacek Nowakowski, Nikola P. Pavletich, Devon A. Thompson, Robert A. Wijnands
  • Patent number: 7326552
    Abstract: Provided are crystals relating to human Ephrin Receptor A2 and its various uses.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: February 5, 2008
    Assignee: Takeda San Diego, Inc.
    Inventors: Ciaran N. Cronin, Jacek Nowakowski, Nikola P. Pavletich, Devon A. Thompson
  • Patent number: 7303892
    Abstract: Provided are crystals relating to AKT3 and its various uses.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: December 4, 2007
    Assignee: Takeda San Diego, Inc.
    Inventors: Eric Adam, Oleg Brodsky, Mark W. Knuth, Jacek Nowakowski, Nikola P. Pavletich, Devon A. Thompson, Robert A. Wijnands
  • Publication number: 20050153966
    Abstract: The invention relates to compounds of the following formula that may be used to inhibits kinases, as well as compositions of matter and kits comprising these compounds. The present invention also relates to methods for inhibiting kinases, as well as treatment methods using compounds according to the present invention.
    Type: Application
    Filed: December 17, 2004
    Publication date: July 14, 2005
    Inventors: Anthony Gangloff, Jacek Nowakowski, Bheema Paraselli, Jeffrey Stafford, Michael Tennant